文献速递外周动脉疾病

门诊血管内中心下肢动脉粥样硬化斑块旋切术的结局

Outcomes of atherectomy for lower extremity ischemia in an office endovascular center.
PubMed 文献 · J Vasc Surg · 2019-09-10

本研究回顾性分析了2011至2016年间在门诊血管内中心由五位血管外科医生实施的352例下肢动脉粥样硬化斑块旋切术。结果显示,联合血管成形术和/或支架植入的斑块旋切术通畅率满意且并发症少,无症状的>50%再狭窄无需干预,不同旋切设备可能影响结局。

要点

  • 斑块旋切联合血管成形术和/或支架植入在门诊中心安全有效,12个月一期通畅率90%。
  • 无症状的>50%再狭窄不推荐再次干预,除非出现临床症状。
  • 激光旋切较轨道旋切闭塞风险显著增高(OR 2.552)。

核心结论

  • 在门诊血管内中心,斑块旋切联合血管成形术和/或支架植入可获得满意的通畅率且并发症极少。
  • 无症状的>50%再狭窄无需再次干预,除非患者出现临床症状。
  • 不同斑块旋切设备可能产生不同的结局。

研究设计与样本

  • 回顾性研究,纳入2011至2016年间在门诊血管内中心由五位委员会认证血管外科医生实施的352例下肢动脉粥样硬化斑块旋切血运重建术。
  • 患者接受激光旋切或轨道旋切,随后根据需要行血管成形术或血管成形术加支架植入。
  • 共治疗282例患者的352条肢体,平均年龄69±11岁。
  • 数据分析采用Kaplan-Meier生存曲线。

主要发现

  • 血管造影显示残余狭窄<30%的技术成功率为571/594条血管。
  • 术后30天内,23/352条肢体因预先存在的疾病需要大截肢(Rutherford 4级3条,5级17条,6级3条),无30天死亡。
  • 571条治疗血管的12个月一期通畅率为90%,29个月为84%。
  • 随访时狭窄>50%且需要再次干预的血管(51/571)与不需要再次干预的血管(79/571)在23个月随访时的通畅率分别为72%和87%,闭塞风险无差异(P = .181)。
  • 激光旋切较轨道旋切闭塞风险显著增加(比值比2.552;95%置信区间1.375-4.735;P = .003)。

临床怎么用

  • 在门诊血管内中心,斑块旋切联合血管成形术和/或支架植入可作为下肢动脉血运重建的安全有效选择。
  • 对于无症状的>50%再狭窄,避免常规再次干预,应基于临床症状和影像学证据决定。
  • 选择旋切设备时需考虑激光旋切可能增加闭塞风险。

局限性

  • 本研究为回顾性设计。
  • 数据来自单中心门诊血管内中心。
  • 样本量有限,共282例患者352条肢体。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the safety and effectiveness of infrainguinal artery revascularization via atherectomy supplemented with other endovascular techniques in an office endovascular center (OEC) setting. METHODS: A retrospective study was conducted examining 352 lower extremity atherectomy revascularization procedures between 2011 and 2016 at an OEC by five board-certified vascular surgeons. Patients received laser atherectomy or orbital atherectomy followed by angioplasty or angioplasty and stent placement as needed. Reintervention was indicated based on evidence of clinical symptoms and imaging studies. Demographics, vessel-specific data, treatment information, and outcome of procedures were recorded. Data analysis was carried out using Kaplan-Meier survival curves. RESULTS: Lower extremity atherectomy was carried out in 282 patients in 352 limbs with average age of 69 ± 11 years. Technical success of <30% residual stenosis by angiogram was achieved in 571/594 vessels treated. Within 30 days of procedure, 23/352 limbs required major amputation resulting from pre-existing disease, ranging from 3 Rutherford class 4, 17 Rutherford class 5, to 3 Rutherford class 6 limbs. No 30-day mortality was noted. The primary patency of the 571 treated vessels at 12 months was 90%, and 84% at 29 months. The patency of treated vessels that reached >50% stenosis on follow-up and required reintervention (51/571 vessels) or did not require reintervention (79/571) was 72% and 87% at 23 months' follow-up, respectively, with no difference in risk of occlusion identified (P = .181). There was a significantly increased risk of occlusion for vessels treated with laser atherectomy as compared with orbital atherectomy (odds ratio, 2.552; 95% confidence interval, 1.375-4.735; P = .003). No significant difference in risk of occlusion was found between treatment with atherectomy and angioplasty (466/571 vessels) compared with atherectomy, angioplasty, and stenting (102/571) with secondary patency of 90% and 85% at 6 months' follow-up, respectively. There was no difference in patency between claudicants and patients with critical limb ischemia. CONCLUSIONS: Atherectomy in conjunction with angioplasty and/or stenting has satisfactory patency with minimal complications when the procedure is carried out in an OEC. Asymptomatic >50% restenosis of treated vessels does not warrant reintervention unless the patient presents with clinical symptoms. Various atherectomy devices may result in different outcomes.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Lai SH, Roush BB, Fenlon J, et al. Outcomes of atherectomy for lower extremity ischemia in an office endovascular center. J Vasc Surg. 2019. PMID: 31519512. doi:10.1016/j.jvs.2019.06.198

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。